OrbusNeich Medical Group HoldingsFRA:Q8T 96 Interest Coverage is 421.13 as of Dec. 2025, which is 2229% above its 10-year median of 18.08. GuruFocus rates FRA:Q8T with a GF Score™ of 96/100 and a GF Value™ of €0.47. The stock has 2 warning signs investors should review. Among 466 Medical Devices & Instruments companies, OrbusNeich Medical Group Holdings ranks better than 83.05% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. OrbusNeich Medical Group Holdings's
Operating Income
for the
six
months ended in Dec. 2025 was €20.2 Mil. OrbusNeich Medical Group Holdings's Interest Expense for the
six
months ended in Dec. 2025 was €-0.0 Mil.
OrbusNeich Medical Group Holdings's interest coverage for the quarter that ended in Dec. 2025 was 421.13.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. OrbusNeich Medical Group Holdings Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for OrbusNeich Medical Group Holdings's Interest Coverage or its related term are showing as below:
FRA:Q8T'
s Interest Coverage Range Over the Past 10 Years
Min: 3.63 Med: 18.08 Max: 293.92
Current: 237.24
FRA:Q8T's Interest Coverage is ranked better than 83.05% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs FRA:Q8T: 237.24
OrbusNeich Medical Group Holdings (FRA:Q8T) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
OrbusNeich Medical Group Holdings Interest Coverage Related Terms
OrbusNeich Medical Group Holdings Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
OrbusNeich Medical Group Holdings Interest Coverage Chart
FRA:Q8T vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Interest Coverage distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's Interest Coverage falls into.
OrbusNeich Medical Group Holdings Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings (FRA:Q8T) has a Interest Coverage of 421.13 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is 2229% above median its historical median of 18.08. Over the past decade, OrbusNeich Medical Group Holdings' Interest Coverage has ranged from 3.63 to 293.92. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #79 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 17%.
Is OrbusNeich Medical Group Holdings' Interest Coverage too high?
OrbusNeich Medical Group Holdings' current Interest Coverage of 421.13 is 2229% above median its 10-year median of 18.08. Over the past 10 years, this metric has ranged from a low of 3.63 to a high of 293.92. The Medical Devices & Instruments industry median Interest Coverage is 15.88. OrbusNeich Medical Group Holdings' value of 421.13 is 2552.8% above this industry median. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #79 out of 466 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #79 out of 466 companies for Interest Coverage. This places OrbusNeich Medical Group Holdings in the top 17% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 15.88. OrbusNeich Medical Group Holdings' value of 421.13 is 2552.8% above this benchmark. Historically, OrbusNeich Medical Group Holdings' own Interest Coverage has ranged from 3.63 to 293.92 over the past decade. While the company's 10-year median is 18.08 vs. the industry median of 15.88, OrbusNeich Medical Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current Interest Coverage of 421.13 is 2552.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current Interest Coverage is 421.13, which is 2229% above median its own 10-year median of 18.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current Interest Coverage of 421.13. The stock's GF Value™ is €0.47, compared to a current price of €0.37 — trading 21.3% below its estimated fair value. The current Interest Coverage is 421.13, which is 2229% above median its 10-year median of 18.08 and 2552.8% above the Medical Devices & Instruments industry median of 15.88. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current Interest Coverage is 421.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued.
The current stock price of €0.37 is trading 21.3% below its estimated GF Value™ of €0.47.
Key valuation signals for FRA:Q8T:
Interest Coverage: 421.13 (2229% above median its 10-year median of 18.08)
GF Value™: €0.47 vs. price of €0.37 (21.3% below fair value)
Industry Position: 2552.8% above the Medical Devices & Instruments median (#79 of 466)
No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrbusNeich Medical Group Holdings Business Description
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score
Get the complete analysis for FRA:Q8T
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Q8T has been successfully added to your 
